-
1Academic Journal
المؤلفون: I. S. Dolgopolov, A. M. Mnatsakanian, A. V. Ivanova, A. D. Volianskaya, E. A. Nakhodnova, M. YuU. Rykov, A. V. Zaitseva, И. С. Долгополов, А. М. Мнацаканян, А. В. Иванова, А. Д. Волянская, Е. А. Находнова, М. Ю. Рыков, А. В. Зайцева
المصدر: Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics); Том 69, № 2 (2024); 72-77 ; Российский вестник перинатологии и педиатрии; Том 69, № 2 (2024); 72-77 ; 2500-2228 ; 1027-4065
مصطلحات موضوعية: лечение, immune thrombocytopenia, practice guideline, first-line therapy, иммунная тромбоцитопения, клинические рекомендации
وصف الملف: application/pdf
Relation: https://www.ped-perinatology.ru/jour/article/view/1973/1480; Rodeghiero F., Stasi R., Gernsheimer T., Michel M., Provan D., Arnold D. et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: Report from an international working group. Blood 2009; 113(11): 2386–2393. DOI:10.1182/blood-2008–07–162503; Consolini R., Legitimo A., Caparello M.C. The Centenary of Immune Thrombocytopenia — Part 1: Revising Nomenclature and Pathogenesis. Front Pediatr 2016; 4: 102. DOI:10.3389/fped.2016.00102; Provan D., Semple J.W. Recent advances in the mechanisms and treatment of immune thrombocytopenia. EBioMedicine 2022; 76: 103820. DOI:10.1016/j.ebiom.2022.103820; Министерство Здравоохранения Российской Федерации, Клинические рекомендации. Иммунная тромбоцитопения. ID699, 2021–2023 гг.; Schoonen W.M., Kucera G., Coalson J., Li L., Rutstein M., Mowat F. et al. Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database. Br J Haematol 2009; 145(2): 235–244. DOI:10.1111/j.1365–2141.2009.07615.x; Provan D., Arnold D.M., Bussel J.B., Chong B.H., Cooper N., Gernsheimer T. et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv 2019; 3: 3780–3817. DOI:10.1182/bloodadvances.2019000812; Heitink-Pollé K.M.J., Uiterwaal C.S.P.M., Porcelijn L., Tamminga R.Y.J., Smiers F.J., Van Woerden N.L. et al. Intrave-thrombocytopenia: A randomized controlled trial. Blood 2018; 132: 883–891. DOI:10.1182/blood-2018–02–830844; Постановление Правительства Российской Федерации от 17.11.2021 № 1968 «Об утверждении Правил поэтапного перехода медицинских организаций к оказанию медицинской помощи на основе клинических рекомендаций, разработанных и утвержденных в соответствии с частями 3, 4, 6–9 и 11 статьи 37 Федерального закона «Об основах охраны здоровья граждан в Российской Федерации»; Федеральный закон от 21.11.2011 № 323-ФЗ «Об основах охраны здоровья граждан в Российской Федерации»; Neunert C., Terrell D.R., Arnold D.M., Buchanan G., Cines D.B., Cooper N. et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv 2019; 3(23): 3829–3866. DOI:10.1182/bloodadvances.2019000966; Bennett C.M., Neunert C., Grace R.F., Buchanan G., Imbach P., Vesely S.K., Kuhne T. Predictors of remission in children with newly diagnosed immune thrombocytopenia: Data from the Intercontinental Cooperative ITP Study Group Registry II participants. Pediatr Blood Cancer 2018; 65(1). DOI:10.1002/pbc.26736; Hsieh Y.L., Lin L.H. Thrombocytopenic purpura following vaccination in early childhood: experience of a medical center in the past 2 decades. J Chin Med Assoc 2010; 73(12): 634–637. DOI:10.1016/S1726–4901(10)70138–6; Faki Osman M.E. Childhood immune thrombocytopenia: Clinical presentation and management. Sudan J Paediatr 2012; 12(1): 27–39; Arnold D.M. Bleeding complications in immune thrombocytopenia. Hematology Am Soc Hematol Educ Program 2015; 2015: 237–242. DOI:10.1182/asheducation-2015.1.237; Witmer C.M., Lambert M.P., O’Brien S.H., Neunert C. Multicenter Cohort Study Comparing U.S. Management of Inpatient Pediatric Immune Thrombocytopenia to Current Treatment Guidelines. Pediatr Blood Cancer 2016; 63(7): 1227–1231. DOI:10.1002/pbc.25961; Consolini R., Costagliola G., Spatafora D. The Centenary of Immune Thrombocytopenia-Part 2: Revising Diagnostic and Therapeutic Approach. Front Pediatr 2017; 5: 179. DOI:10.3389/fped.2017.00179; Provan D., Stasi R., Newland A.C., Blanchette V.S., Bolton-Maggs P., Bussel J.B. et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010; 115(2): 168–186. DOI:10.1182/blood-2009–06–225565; Carcao M.D., Zipursky A., Butchart S., Leaker M., Blanchette V.S. Short-course oral prednisone therapy in children presenting with acute immune thrombocytopenic purpura (ITP). Acta Paediatr 1998; 424: 71–74. DOI:10.1111/j.1651–2227.1998.tb01239.x; Matzdorff A., Meyer O., Ostermann H., Kiefel V., Eberl W., Kühne T. et al. Immune Thrombocytopenia — Current Diagnostics and Therapy: Recommendations of a Joint Working Group of DGHO, ÖGHO, SGH, GPOH, and DGTI. Oncol Res Treat 2018; 41(5): 1–30. DOI:10.1159/000492187; Terrell D.R., Neunert C.E., Cooper N., Heitink-Pollé K.M., Kruse C. et al. Immune Thrombocytopenia (ITP): Current Limitations in Patient Management. Medicina (Kaunas) 2020; 56(12): 667. DOI:10.3390/medicina56120667; Kuhne T., Freedman J., Semple J.W., Doyle J., Butchart S., Blanchette V.S. Platelet and immune responses to oral cyclic dexamethasone therapy in childhood chronic immune thrombocytopenic purpura. J Pediatr 1997; 130(1): 17–24. DOI:10.1016/S0022–3476(97)70305–6; Beck C.E., Nathan P.C., Parkin P.C., Blanchette V.S., Macarthur C. Corticosteroids versus intravenous immune globulin for the treatment of acute immune thrombocytopenic purpura in children: a systematic review and meta-analysis of randomized controlled trials. J Pediatr 2005; 147(4): 521–527. DOI:10.1016/j.jpeds.2005.04.032; https://www.ped-perinatology.ru/jour/article/view/1973